- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 239/10 - Atomes d'oxygène ou de soufre
Détention brevets de la classe C07D 239/10
Brevets de cette classe: 110
Historique des publications depuis 10 ans
|
1
|
8
|
5
|
5
|
4
|
6
|
6
|
14
|
0
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Bayer AG | 3470 |
4 |
| Abbvie Inc. | 1837 |
4 |
| The Regents of the University of California | 20590 |
3 |
| F. Hoffmann-La Roche AG | 7847 |
2 |
| Abbott Laboratories | 2272 |
2 |
| FUJIFILM Corporation | 30327 |
2 |
| Board of Regents, The University of Texas System | 6065 |
2 |
| University of Southern California | 2123 |
2 |
| ADAMA Agan Ltd. | 433 |
2 |
| Aposense Ltd. | 33 |
2 |
| Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 824 |
2 |
| Dong-A Pharmaceutical Co., Ltd. | 79 |
2 |
| Dr. Reddy's Laboratories Limited | 557 |
2 |
| Melior Pharmaceuticals I, Inc. | 25 |
2 |
| Purdue Pharmaceutical Products L.P. | 32 |
2 |
| Ra Pharmaceuticals, Inc. | 42 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2980 |
2 |
| University of Tsukuba | 631 |
2 |
| Vitae Pharmaceuticals, Inc. | 87 |
2 |
| Yale University | 2499 |
2 |
| Autres propriétaires | 65 |